Inhibition of Protein Synthesis by Chromium(VI) Differentially Affects Expression of Urokinase and Its Receptor in Human Type II Pneumocytes

This publication has 32 references indexed in Scilit:

• Expression and Activity of Urokinase and Its Receptor in Endothelial and Pulmonary Epithelial Cells Exposed to Asbestos
  Toxicology and Applied Pharmacology, 1998
• Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos.
  Environmental Health Perspectives, 1997
• Apoptosis Is the Mode of Cell Death Caused by Carcinogenic Chromium
  Toxicology and Applied Pharmacology, 1994
• The genotoxic carcinogen chromium(VI) alters the metal-inducible expression but not the basal expression of the metailothionein gene in vivo
  Carcinogenesis: Integrative Cancer Research, 1994
• Physiological consequences of loss of plasminogen activator gene function in mice
  Nature, 1994
• Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
  Proceedings of the National Academy of Sciences, 1990
• Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress Syndrome
  New England Journal of Medicine, 1990
• Chromium Toxicity and Carcinogenesis
  Published by Elsevier ,1990
• Chromium cross-links glutathione and cysteine to DNA
  Carcinogenesis: Integrative Cancer Research, 1989
• Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability
  Biochemical Journal, 1987